Open archive
Clear filters
Showing 145-168 of 756 published briefings.
NZX results archive
NZX company results and financial reports.
Read what changed in the latest company results, compare equivalent periods, and open issuer-labelled annual reports and other source documents where available.
Iperion (IPR)HY26Released 24 November 2025
Iperion's asset base fell to NZ$0.3m, the smallest on record
The half-year loss narrowed and cash burn eased, but with zero revenue the company is operating from its lowest asset base in the supplied historical
Published 28 April 2026
Read briefingMetro Performance Glass (MPG)HY26Released 24 November 2025
Recapitalisation cut net debt to $27.4m, leverage from 6.0x to 2.9x
PBT swung 167.1% to $4.5m profit on lower interest and a tax credit, but EBITDA margin sat at the lower edge of MPG's historical range at 8.8%.
Published 22 April 2026
Read briefingGentrack Group (GTK)FY25Released 24 November 2025
PBT rose 38.4% but operating cash fell 36% as conversion halved
A 3.1% effective tax rate flattered NPAT to a 120% gain while OCF/EBITDA fell to 79.2% from 145.7% on working-capital normalisation.
Published 22 April 2026
Read briefingKingfish (KFL)HY26Released 24 November 2025
Portfolio return halved to NZ$20.0m but investment income hit a record NZ$5.9m
NPAT fell 61.7% to NZ$16.4m as fair-value gains receded against a near-flat benchmark, while NTA per share slipped 5.2% to NZ$1.34.
Published 22 April 2026
Read briefingKiwi Property Group (KPG)HY26Released 24 November 2025
NTA per share fell 4.3% to $1.12 even as operating profit rose 11.5%
Valuation pressure and a 58.6% effective tax rate cut NPAT to $9.8m, while pre-lease free cash flow swung to $18.9m on lower capex.
Published 21 April 2026
Read briefingGeneral Capital (GEN)HY26Released 21 November 2025
PBT fell 31.8% on 19% revenue growth as costs and book outpaced earnings
Around NZ$0.6m of exceptional first-half costs pushed ROE to 3.4% from 5.5% even as total assets grew 47.2% to NZ$275.8m.
Published 22 April 2026
Read briefingOceania Healthcare (OCA)HY26Released 21 November 2025
OCA swung to PBT positive but capex jumped 82% to 40.4% of revenue
EBITDA rose 7.4% on flat revenue and PBT turned positive at $1.0m, but a doubled investment cycle kept free cash flow at -$8.4m.
Published 21 April 2026
Read briefingEROAD (ERD)HY26Released 21 November 2025
EROAD swings to a $144.2m net loss despite $28.7m EBITDA and stronger cash flow
Cash conversion rose to 89.5% and EBITDA held near prior levels, yet an unexplained $136.6m pretax loss cut equity to $186.8m.
Published 21 April 2026
Read briefingMy Food Bag Group (MFB)HY26Released 20 November 2025
Revenue grew 3.8% but a $4.4m working-capital build drained cash
Trade debtors swelled to $4.6m from $0.6m while a 19.8% tax rate cushioned NPAT against a 12.2% PBT decline.
Published 22 April 2026
Read briefingGoodman Property Trust (GNZ)HY26Released 20 November 2025
Gross borrowings fell 53% as PBT rose 17.1% on issuer transition
Cash rose to $531.8m and total assets fell $663.1m, signalling a material balance sheet reshape that complicates the like-for-like read.
Published 22 April 2026
Read briefingGoodman Property Trust (GMT)HY26Released 20 November 2025
Borrowings cut 76% via Highbrook Fund deal as PBT grew 17.1%
A 0.6% effective tax rate lifted NPAT 35.8%, but the cleaner 17.1% PBT growth and 5.2% like-for-like rental uplift set the operating read.
Published 21 April 2026
Read briefingNapier Port Holdings (NPH)FY25Released 19 November 2025
Capex doubled to 16.1% of revenue, lifting FCF payout to 78%
Reported NPAT +24.6% is flattered by a tax-rate drop from 33.5% to 28.3%; cleaner PBT growth of 15.5% sits within Napier Port's historical range.
Published 18 May 2026
Read briefingRadius Residential Care (RAD)HY26Released 19 November 2025
PBT up 204% on 19% revenue growth as cash conversion lifted to 89%
A lower effective tax rate flattered NPAT, but EBITDA +41% and leverage cut to 4.3x point to genuine operating gains.
Published 23 April 2026
Read briefingAsset Plus (APL)HY26Released 19 November 2025
Debt fully repaid and FFO turned positive as NPAT fell 30.4%
Graham Street disposal left Asset Plus with NZ$10.3m cash and zero borrowings, but the smaller portfolio means headline profit is not comparable.
Published 22 April 2026
Read briefingSanford (SAN)FY25Released 18 November 2025
PBT up 140.6% on flat revenue with gross borrowings cut to $105.0m
Operating recovery is real but NPAT growth of 223.4% is amplified by an effective tax rate that fell from 47.4% to 29.2%.
Published 29 April 2026
Read briefingSerko (SKO)HY26Released 2025-11-18T08:37:34+13:00
Serko's PBT loss widened 84.4% despite 47.4% revenue growth
Revenue accelerated on the GetThere acquisition but losses deepened and working capital expanded even as cash generation improved.
Published 23 April 2026
Read briefingInfratil (IFT)HY26Released 13 November 2025
NPAT swung +385% on $280m disposal gain while cash conversion fell to 6.4%
Headline result is distorted by portfolio divestments and a discontinued operation; operational EBITDAF rose only 7% to $514m and OCF fell 64.9%.
Published 21 April 2026
Read briefingHenderson Far East Income (HFL)FY25Released 12 November 2025
Distribution cover halved to 100% as portfolio trailed benchmark again
Investment income fell 3.1% to NZ$50.6m and the 12.7% NAV total return lagged the 14.1% benchmark, leaving the dividend just covered.
Published 22 April 2026
Read briefingScott Technology (SCT)FY25Released 21 October 2025
PBT up 58% on margin lift, but receivable days stretched to 79
Materials Handling and Protein margins drove earnings on flat revenue, yet trade debtors absorbed $19.4m as days outstanding lengthened.
Published 20 April 2026
Read briefingHallenstein Glasson (HLG)FY25Released 26 September 2025
PBT grew 12.1% on 8.1% revenue with cash reserves at $58.3m
Operating leverage and a lower tax rate lifted NPAT 14.5%, but implied H2 NPAT eased to $18.3m and the payout ratio jumped to 83.1%.
Published 20 April 2026
Read briefingNew Zealand King Salmon Investments (NZK)HY26Released 25 September 2025
NPAT swung to a $20.8m loss on a $31.2m biological asset write-down
Operating cash flow rose 21.2% to $19.6m, but volumes fell 17% and FY26 pro-forma EBITDA guidance of just $1-7m points to genuine operating pressure.
Published 23 April 2026
Read briefingKMD Brands (KMD)FY25Released 24 September 2025
PBT loss widened 124% to $104.7m on flat revenue as Kathmandu swung to loss
Second-half EBITDA turned negative and the dividend was scrapped, signalling deeper operating pressure than headline 1.0% sales growth suggests.
Published 20 April 2026
Read briefingBriscoe Group (BGP)HY26Released 10 September 2025
Margins compressed to historical floor while dividend exceeds free cash flow
PBT margin at 11.0% sits at the bottom of the four-year range and the interim dividend consumes 227.8% of $9.8m pre-lease free cash flow.
Published 22 April 2026
Read briefingRua Bioscience (RUA)FY25Released 1 September 2025
RUA revenue rose 490.6% but the business remains deeply cash-negative
Strong commercial momentum cut the loss before tax by 74.8%, yet cash fell to NZD 0.2m and operating outflows persist, making runway the central
Published 19 May 2026
Read briefingGet reporting-season briefings
Get full NZX result briefings by email as new coverage is published.